Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.

The use of CNI-based therapy in individuals exposed to multiple classes of prior biologic therapies leads to a significantly increased risk of 1-year colectomy. Future studies will be required to compare inpatient management strategies with the expanding novel therapies in UC.